// App-Quantinova.ai

6076 : Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH).

Researchers

Presenter

  • Yungan Tao

Principal Investigators

  • Anne Auperin

  • Xu Shan Sun

  • Christian Sire

  • Laurent Martin

  • G Bera

  • Alexandre Coutte

  • Jessica Miroir

  • Cedrik Lafond

  • Natacha Colin-Batailhou

  • Aline Maillard

  • Laurent Gibel

  • Cecile Michel

  • Joel Guigay

  • Jean Bourhis

Medical Centers

  • Institut Gustave-Roussy, Villejuif, France

  • CHRU Jean Minjoz, Besancon Cedex, France

  • CH de Bretagne Sud, Lorient, France

  • Radiotherapie, Centre G Le Conquerant, Le Havre, France

  • Centre Hospitalier de Bretagne Sud, Lorient, France

  • Department of Radiotherapie, CHU Amiens, Amiens, France

  • Clermont Ferrand, Clermont Ferrand, France

  • Clinique Victor Hugo, Le Mans, France

  • GORTEC, Tours, France

  • Pole de Sante Publique, Service dInformation Medicale, Unite de Soutien Methodologique a la Recherche Clinique et Epidemiologique, CHU de Bordeaux, Bordeaux, France

  • Department of Medical Oncology, Antoine Lacassagne Comprehensive Cancer Centre, FHU Oncoage, Nice, France

  • Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Locations

  • France

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Erbitux

  • Cisplatin

  • Avelumab

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Cohort

Phase

  • III

Study Id's

  • NCT02999087

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved